Search Results

There are 3791 results for: content related to: UR-144 in products sold via the Internet: Identification of related compounds and characterization of pyrolysis products

  1. Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11

    Drug Testing and Analysis

    Line Marie Nielsen, Niels Bjerre Holm, Lars Olsen and Kristian Linnet

    Version of Record online : 11 SEP 2015, DOI: 10.1002/dta.1860

  2. Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization

    Drug Testing and Analysis

    Volume 5, Issue 1, January 2013, Pages: 27–45, Delphine Psychoyos and K. Yaragudri Vinod

    Version of Record online : 13 AUG 2012, DOI: 10.1002/dta.1390

  3. Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens

    Drug Testing and Analysis

    Volume 7, Issue 6, June 2015, Pages: 483–493, Marisol S. Castaneto, Karl B. Scheidweiler, Adarsh Gandhi, Ariane Wohlfarth, Kevin L. Klette, Thomas M. Martin and Marilyn A. Huestis

    Version of Record online : 17 SEP 2014, DOI: 10.1002/dta.1709

  4. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids

    Drug Testing and Analysis

    Volume 4, Issue 10, October 2012, Pages: 745–753, Tim Sobolevsky, Ilya Prasolov and Grigory Rodchenkov

    Version of Record online : 5 OCT 2012, DOI: 10.1002/dta.1418

  5. Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue

    Drug Testing and Analysis

    Volume 7, Issue 2, February 2015, Pages: 131–142, Tim Sobolevsky, Ilya Prasolov and Grigory Rodchenkov

    Version of Record online : 26 NOV 2014, DOI: 10.1002/dta.1756

  6. Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1H-indol-3-yl(adamantan-1-yl)methanone

    Drug Testing and Analysis

    Andreas Carlsson, Sandra Lindberg, Xiongyu Wu, Simon Dunne, Martin Josefsson, Crister Åstot and Johan Dahlén

    Version of Record online : 3 NOV 2015, DOI: 10.1002/dta.1904

  7. Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 832–839, Ruri Kikura-Hanajiri, Nahoko Uchiyama, Maiko Kawamura and Yukihiro Goda

    Version of Record online : 26 DEC 2013, DOI: 10.1002/dta.1584

  8. Identification and quantification of synthetic cannabinoids in ‘spice-like’ herbal mixtures: A snapshot of the German situation in the autumn of 2012

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 59–71, Nico Langer, Rainer Lindigkeit, Hans-Martin Schiebel, Ludger Ernst and Till Beuerle

    Version of Record online : 30 MAY 2013, DOI: 10.1002/dta.1499

  9. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes

    Drug Testing and Analysis

    Volume 7, Issue 3, March 2015, Pages: 187–198, Adarsh S. Gandhi, Ariane Wohlfarth, Mingshe Zhu, Shaokun Pang, Marisol Castaneto, Karl B. Scheidweiler and Marilyn A. Huestis

    Version of Record online : 14 MAY 2014, DOI: 10.1002/dta.1662

  10. Synthetic cannabimimetic agents metabolized by carboxylesterases

    Drug Testing and Analysis

    Volume 7, Issue 7, July 2015, Pages: 565–576, Ragnar Thomsen, Line M. Nielsen, Niels B. Holm, Henrik B. Rasmussen, Kristian Linnet and the INDICES Consortium

    Version of Record online : 24 OCT 2014, DOI: 10.1002/dta.1731

  11. Legal controls on cannabimimetics: An international dilemma?

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 80–87, L. A. King

    Version of Record online : 23 JUL 2013, DOI: 10.1002/dta.1510

  12. Acute intoxication by synthetic cannabinoids – Four case reports

    Drug Testing and Analysis

    Volume 5, Issue 9-10, September-October 2013, Pages: 790–794, Maren Hermanns-Clausen, Stefan Kneisel, Melanie Hutter, Bela Szabo and Volker Auwärter

    Version of Record online : 20 MAY 2013, DOI: 10.1002/dta.1483

  13. Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry

    Drug Testing and Analysis

    Volume 5, Issue 8, August 2013, Pages: 657–669, Stefan Kneisel, Volker Auwärter and Jürgen Kempf

    Version of Record online : 18 OCT 2012, DOI: 10.1002/dta.1429

  14. Structure elucidation of the designer drug N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-3-(4-fluorophenyl)-pyrazole-5-carboxamide and the relevance of predicted 13C NMR shifts – a case study

    Drug Testing and Analysis

    Ulrich Girreser, Peter Rösner and Andrej Vasilev

    Version of Record online : 27 MAY 2015, DOI: 10.1002/dta.1820

  15. Identification of three cannabimimetic indazole and pyrazole derivatives, APINACA 2H-indazole analogue, AMPPPCA, and 5F-AMPPPCA

    Drug Testing and Analysis

    Wei Jia, Xin Meng, Zhenhua Qian, Zhendong Hua, Tao Li and Cuimei Liu

    Version of Record online : 9 MAR 2016, DOI: 10.1002/dta.1967

  16. The synthesis and characterization of the ‘research chemical’ N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide (3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer

    Drug Testing and Analysis

    Gavin McLaughlin, Noreen Morris, Pierce V. Kavanagh, John D. Power, Brendan Twamley, John O'Brien, Brian Talbot, Geraldine Dowling and Simon D. Brandt

    Version of Record online : 11 SEP 2015, DOI: 10.1002/dta.1864

  17. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry

    Drug Testing and Analysis

    Svante Vikingsson, Henrik Gréen, Linda Brinkhagen, Shahzabe Mukhtar and Martin Josefsson

    Version of Record online : 11 NOV 2015, DOI: 10.1002/dta.1896

  18. In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA

    Drug Testing and Analysis

    Volume 7, Issue 10, October 2015, Pages: 866–876, Claudio Erratico, Noelia Negreira, Helia Norouzizadeh, Adrian Covaci, Hugo Neels, Kristof Maudens and Alexander L.N. van Nuijs

    Version of Record online : 12 APR 2015, DOI: 10.1002/dta.1796

  19. The current situation with cannabinoids

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 1–6, Andrew T. Kicman and Leslie A. King

    Version of Record online : 14 JAN 2014, DOI: 10.1002/dta.1597

  20. Pyrolysis of drugs of abuse: a comprehensive review

    Drug Testing and Analysis

    Volume 7, Issue 6, June 2015, Pages: 445–456, Suzanne Bell and Corey Nida

    Version of Record online : 13 APR 2015, DOI: 10.1002/dta.1794